TY - JOUR
T1 - Management and treatment of glomerular diseases (part 1)
T2 - conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
AU - Conference Participants
AU - Floege, Jürgen
AU - Barbour, Sean J.
AU - Cattran, Daniel C.
AU - Hogan, Jonathan J.
AU - Nachman, Patrick H.
AU - Tang, Sydney C.W.
AU - Wetzels, Jack F.M.
AU - Cheung, Michael
AU - Wheeler, David C.
AU - Winkelmayer, Wolfgang C.
AU - Rovin, Brad H.
AU - Adler, Sharon G.
AU - Alpers, Charles E.
AU - Ayoub, Isabelle
AU - Bagga, Arvind
AU - Barratt, Jonathan
AU - Caster, Dawn J.
AU - Chan, Daniel T.M.
AU - Chang, Anthony
AU - Choo, Jason Chon Jun
AU - Cook, H. Terence
AU - Coppo, Rosanna
AU - Fervenza, Fernando C.
AU - Fogo, Agnes B.
AU - Fox, Jonathan G.
AU - Gibson, Keisha L.
AU - Glassock, Richard J.
AU - Harris, David
AU - Hodson, Elisabeth M.
AU - Hoxha, Elion
AU - Iseki, Kunitoshi
AU - Jennette, J. Charles
AU - Jha, Vivekanand
AU - Johnson, David W.
AU - Kaname, Shinya
AU - Katafuchi, Ritsuko
AU - Kitching, A. Richard
AU - Lafayette, Richard A.
AU - Li, Philip K.T.
AU - Liew, Adrian
AU - Lv, Jicheng
AU - Malvar, Ana
AU - Maruyama, Shoichi
AU - Mejía-Vilet, Juan Manuel
AU - Moeller, Marcus J.
AU - Mok, Chi Chiu
AU - Nester, Carla M.
AU - Noiri, Eisei
AU - O'Shaughnessy, Michelle M.
AU - Özen, Seza
N1 - Publisher Copyright:
© 2019 The Author(s)
PY - 2019/2
Y1 - 2019/2
N2 - The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies Conference on glomerular diseases in November 2017. The conference focused on the 2012 KDIGO guideline with the aim of identifying new insights into nomenclature, pathogenesis, diagnostic work-up, and, in particular, therapy of glomerular diseases since the guideline's publication. It was the consensus of the group that most guideline recommendations, in particular those dealing with therapy, will need to be revisited by the guideline-updating Work Group. This report covers general management of glomerular disease, IgA nephropathy, and membranous nephropathy.
AB - The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies Conference on glomerular diseases in November 2017. The conference focused on the 2012 KDIGO guideline with the aim of identifying new insights into nomenclature, pathogenesis, diagnostic work-up, and, in particular, therapy of glomerular diseases since the guideline's publication. It was the consensus of the group that most guideline recommendations, in particular those dealing with therapy, will need to be revisited by the guideline-updating Work Group. This report covers general management of glomerular disease, IgA nephropathy, and membranous nephropathy.
KW - IgA nephropathy
KW - KDIGO
KW - hypertension
KW - kidney biopsy
KW - membranous nephropathy
KW - proteinuria
UR - http://www.scopus.com/inward/record.url?scp=85059848558&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059848558&partnerID=8YFLogxK
U2 - 10.1016/j.kint.2018.10.018
DO - 10.1016/j.kint.2018.10.018
M3 - Article
C2 - 30665568
AN - SCOPUS:85059848558
SN - 0085-2538
VL - 95
SP - 268
EP - 280
JO - Kidney international
JF - Kidney international
IS - 2
ER -